Diabetes In Control.  News and Information for Medical Professionals


Home |  Advertising | All News Categories | Classifieds | Downloads | Education | Features | Feedback | Items of the Week | Links | Most Recent Additions | New Products | NewsFeed | Past Newsletters | Recommend Us | Search | Studies | Subscribe | Test Your Knowledge |  This Week's Newsletter | Tools For Your Practice | Writers Archives 

Test Your Knowledge

 

You are correct...

Diabetes In Control.com  Issue #146

Oral Glucose Tolerance Testing of Obese Patients

Question

Patient Barbara A: 35 yrs old, non-pregnant, weight 145 kg (305 lbs) with extreme abdominal obesity, a metabolic syndrome candidate. How much oral glucose should be use to test her glucose metabolism to determine a diagnosis of diabetes? 

Answer:

1. Use 75 grams of glucose

2. Use a 100 grams of glucose

3.  Use 1.75 grams of glucose per kilogram.

4.  Use a High Carbohydrate Meal of at least 400 grams.

 

For adults, there are no recommendations from the American Diabetes Association (ADA) or World Health Organization (WHO) to alter the dose of the oral glucose challenge based on absolute body mass, lean body mass, or body surface area. At one time, up to 100 grams of glucose were recommended for OGTTs. However, for non-pregnant adults, ADA long ago standardized the dose to 75 grams. In children, 1.75 grams of glucose are used per kilogram to a maximum dose of 75 grams. Also, there are no reference ranges for expected glucose responses to different doses of glucose. Likewise, there are no reference ranges for expected glucose responses in different weight individuals. In short, if we are going to use the current ADA guidelines for the diagnosis of prediabetes or diabetes, a 75-gram OGTT should be performed. 

References

  1. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003;26:S5-S20.
  2. Diabetes Prevention Research Group. Reduction in the evidence of type 2 diabetes with life-style intervention or metformin. N Engl J Med. 2002;346:393-403.
  3. American Diabetes Association. Screening for Type 2 Diabetes. Diabetes Care. 2003;26:S21-S24.
  4. American Diabetes Association, National Institute of Diabetes, Digestive and Kidney Diseases. The Prevention or Delay of Type 2 Diabetes. Diabetes Care. 2003;26:S62-S69.
  5. American Diabetes Association. Gestational Diabetes Mellitus. Diabetes Care. 2003;26:S103-S105.

If you have a unique Patient Question an Answer, please send to us at

publisher@diabetesincontrol.com

Question from Issue #133 

Question from Issue #134

Question from Issue #135

Question from Issue #136

Question from Issue #137

Question from Issue #138

Question from Issue #139

Question from Issue #140

Question from Issue #141

Question from Issue #142

Question from Issue #143

Question from Issue #144

 


Get the FREE Diabetes In Control Newsletter!

  • * Free Diabetes Related Information.
  • * Participation in Current and Future Studies
  • * Participation in Surveys (honorariums)
  • * Information that better helps your patients.
  • * Stay Current with the most updated information on treatments and medical devices.
  • * Learn about new studies......plus much more...

Simply Enter your Email Address Below to begin receiving the FREE Diabetes In Control Weekly Newsletter in your mailbox.
 

Please specify the format you can receive the newsletter in below

HTML Text AOL

Home · About Us · Advertise · Classifieds · Current News · Downloads · Education · Features · Feedback · Links · New Products · Past Newsletters · Recommend Us · Search · Show All Stories · Studies · Subscribe · Test Your Knowledge · Tools For Your Practice · Writers Archives · Search Our Archives · NewsFeed

We subscribe to the HONcode principles of the Health On the Net Foundation

©Copyright 1999-2003 Diabetes In Control

For Questions about this website click here